163 related articles for article (PubMed ID: 32219437)
1. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
Hermanova I; Zúñiga-García P; Caro-Maldonado A; Fernandez-Ruiz S; Salvador F; Martín-Martín N; Zabala-Letona A; Nuñez-Olle M; Torrano V; Camacho L; Lizcano JM; Talamillo A; Carreira S; Gurel B; Cortazar AR; Guiu M; López JI; Martinez-Romero A; Astobiza I; Valcarcel-Jimenez L; Lorente M; Arruabarrena-Aristorena A; Velasco G; Gomez-Muñoz A; Suárez-Cabrera C; Lodewijk I; Flores JM; Sutherland JD; Barrio R; de Bono JS; Paramio JM; Trka J; Graupera M; Gomis RR; Carracedo A
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32219437
[TBL] [Abstract][Full Text] [Related]
2. Lkb1 deficiency causes prostate neoplasia in the mouse.
Pearson HB; McCarthy A; Collins CM; Ashworth A; Clarke AR
Cancer Res; 2008 Apr; 68(7):2223-32. PubMed ID: 18381428
[TBL] [Abstract][Full Text] [Related]
3. The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.
Yang CS; Melhuish TA; Spencer A; Ni L; Hao Y; Jividen K; Harris TE; Snow C; Frierson HF; Wotton D; Paschal BM
Prostate; 2017 Nov; 77(15):1452-1467. PubMed ID: 28875501
[TBL] [Abstract][Full Text] [Related]
4. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
5. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.
Jin L; Chun J; Pan C; Kumar A; Zhang G; Ha Y; Li D; Alesi GN; Kang Y; Zhou L; Yu WM; Magliocca KR; Khuri FR; Qu CK; Metallo C; Owonikoko TK; Kang S
Mol Cell; 2018 Jan; 69(1):87-99.e7. PubMed ID: 29249655
[TBL] [Abstract][Full Text] [Related]
6. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the signaling pathways that mediate cancer in PTEN and LKB1 double-knockout mice.
Chen J; Zhang XD; Proud C
Sci Signal; 2015 Sep; 8(392):pe1. PubMed ID: 26329580
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
Wang S; Gao J; Lei Q; Rozengurt N; Pritchard C; Jiao J; Thomas GV; Li G; Roy-Burman P; Nelson PS; Liu X; Wu H
Cancer Cell; 2003 Sep; 4(3):209-21. PubMed ID: 14522255
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor kinase LKB1: lessons from mouse models.
Ollila S; Mäkelä TP
J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
[TBL] [Abstract][Full Text] [Related]
10. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin.
Zhang W; Gao Y; Li F; Tong X; Ren Y; Han X; Yao S; Long F; Yang Z; Fan H; Zhang L; Ji H
Cancer Res; 2015 Nov; 75(21):4450-7. PubMed ID: 26363011
[TBL] [Abstract][Full Text] [Related]
11. LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway.
Xu P; Cai F; Liu X; Guo L
Int J Clin Exp Pathol; 2014; 7(12):8480-8. PubMed ID: 25674212
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.
Calles A; Sholl LM; Rodig SJ; Pelton AK; Hornick JL; Butaney M; Lydon C; Dahlberg SE; Oxnard GR; Jackman DM; Jänne PA
Clin Cancer Res; 2015 Jun; 21(12):2851-60. PubMed ID: 25737507
[TBL] [Abstract][Full Text] [Related]
14. LKB1 loss of function studied in vivo.
Shorning BY; Clarke AR
FEBS Lett; 2011 Apr; 585(7):958-66. PubMed ID: 21241696
[TBL] [Abstract][Full Text] [Related]
15. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
16. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
17. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
18. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
19. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
[TBL] [Abstract][Full Text] [Related]
20. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism.
Zeng Q; Chen J; Li Y; Werle KD; Zhao RX; Quan CS; Wang YS; Zhai YX; Wang JW; Youssef M; Cui R; Liang J; Genovese N; Chow LT; Li YL; Xu ZX
Oncogene; 2017 Mar; 36(9):1245-1255. PubMed ID: 27546620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]